Technical Analysis for QURE - uniQure N.V.

Grade Last Price % Change Price Change
grade B 28.29 -4.30% -1.27
QURE closed down 4.3 percent on Thursday, December 13, 2018, on 47 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical QURE trend table...

Date Alert Name Type % Chg
Dec 13 Fell Below 20 DMA Bearish 0.00%
Dec 13 Multiple of Ten Bearish Other 0.00%
Dec 13 Outside Day Range Expansion 0.00%
Dec 12 20 DMA Support Bullish -4.30%
Dec 12 Wide Bands Range Expansion -4.30%
Dec 11 20 DMA Support Bullish -1.53%
Dec 11 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.53%
Dec 11 Wide Bands Range Expansion -1.53%
Dec 11 Down 3 Days in a Row Weakness -1.53%
Dec 10 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.45%

Older signals for QURE ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Is QURE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 43.23
52 Week Low 16.71
Average Volume 427,597
200-Day Moving Average 31.7734
50-Day Moving Average 27.808
20-Day Moving Average 28.8065
10-Day Moving Average 29.488
Average True Range 2.1175
ADX 13.23
+DI 21.3228
-DI 20.3541
Chandelier Exit (Long, 3 ATRs ) 28.6475
Chandelier Exit (Short, 3 ATRs ) 28.3325
Upper Bollinger Band 32.5539
Lower Bollinger Band 25.0591
Percent B (%b) 0.43
BandWidth 26.017739
MACD Line 0.3346
MACD Signal Line 0.3033
MACD Histogram 0.0313
Fundamentals Value
Market Cap 723.09 Million
Num Shares 25.6 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -10.03
Price-to-Sales 16.30
Price-to-Book 14.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.53
Resistance 3 (R3) 31.86 31.12 30.99
Resistance 2 (R2) 31.12 30.29 30.95 30.81
Resistance 1 (R1) 29.70 29.78 29.33 29.37 30.63
Pivot Point 28.96 28.96 28.77 28.79 28.96
Support 1 (S1) 27.54 28.13 27.17 27.21 25.95
Support 2 (S2) 26.80 27.62 26.63 25.77
Support 3 (S3) 25.38 26.80 25.59
Support 4 (S4) 25.05